GIFLF (GIFLF) Stock Price & Analysis
GIFLF (GIFLF) rose 0.00% to USD 10.25 as of July 25, 2026 at 01:45 UTC, according to Nexqual real-time market data.
GIFLF last closed at USD 10.25; the session ranged USD 10.45–10.45 on volume of 5,781 shares. Market capitalization is $6.98B, with a 52-week range of USD 10.13–13.9 (PNK). Source: Nexqual, July 25, 2026 at 01:45 UTC.
Key Statistics (as of July 25, 2026 at 01:45 UTC)
| Price | USD 10.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.25 |
| Open | USD 10.45 |
| Day Range | USD 10.45 – 10.45 |
| 52-Week Range | USD 10.13 – 13.9 |
| Volume | 5,781 shares |
| Market Cap | $6.98B |
| Exchange | PNK |
Technical Analysis (GIFLF)
Nexqual's technical model rates GIFLF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 20.8 (oversold) |
| vs SMA50 | Below (USD 10.61) |
| MACD | -0.1 (negative) |
Analyst Ratings (GIFLF)
Wall Street analysts rate GIFLF "None", per Nexqual as of July 25, 2026 at 01:45 UTC.
| Consensus Rating | None |
|---|
Earnings (GIFLF)
| Next Earnings Date | 2026-07-28 |
|---|---|
| Revenue Estimate | $1.89B |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financials & Fundamentals (GIFLF)
| Total Revenue | $7.44B |
|---|---|
| Revenue Growth (YoY) | -4.80% |
| Gross Margin | +38.36% |
| Operating Margin | +16.47% |
| Profit Margin | +5.58% |
| ROE | +6.13% |
| Debt / Equity | 123.22 |
| Current Ratio | 2.47 |
| Total Cash | $702.00M |
| Total Debt | $9.67B |
| Free Cash Flow | $887.54M |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financial Health Score (GIFLF)
Nexqual rates GIFLF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:45 UTC.
| Growth | Mixed — Revenue +4.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 16% |
| Balance Sheet | Mixed — $702M cash vs $9.67B debt |
| Cash Flow | Solid — FCF $888M, 12% margin |
| Efficiency | Mixed — ROE 6%, ROA 4.2% |
Ownership (GIFLF)
| Insider Ownership | +31.19% |
|---|---|
| Institutional Ownership | +36.58% |
| Shares Outstanding | 422.36M |
| Float | 418.12M |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Leadership (GIFLF)
GIFLF is led by Jose Ignacio Abia Buenache (age 57), CEO & Director, per Nexqual as of July 25, 2026 at 01:45 UTC.
| CEO & Director | Jose Ignacio Abia Buenache (age 57) |
|---|---|
| Chief Financial Officer | Rahul Srinivasan (age 48) |
| Senior Vice President of Strategy & COO Office | Lluis Pons Gomez (age 41) |
| Head of Investor Relations & Sustainability and Vice President | Daniel Segarra |
| President of Commercial Tech Support | Sergio Roura Adell (age 56) |
Major Backers & Investors (GIFLF)
Notable institutional backers of GIFLF include DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT., Fidelity, Charles Schwab, according to Nexqual as of July 25, 2026 at 01:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT. | 0.51% |
| Fidelity | 0.26% |
| Charles Schwab | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.82% |
| BlackRock | 0.72% |
| Dimensional Fund Advisors | 0.25% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GIFOF | Grifols Sa | USD 8.85 | ▲ 0% |
| GIKLY | Grifols Sa | USD 5.1 | ▲ 0% |
| DSKYF | Daiichi Sankyo Co., Ltd. | USD 17.52 | ▲ 2.88% |
| ALPMF | Astellas Pharma, Inc. | USD 12.85 | ▲ 0% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22 | ▼ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:45 UTC. This page is informational and not investment advice.